ASCO GI 2022 Highlights: Host-Related Biomarkers Including Gut Microbiome to Predict Toxicities of Nivolumab in Advanced Gastric Cancer - DELIVER Trial (JACCRO GC-08)

184 views
January 26, 2022
0 Comments
Login to view comments. Click here to Login